ACE and hepatocellular carcinoma: Although the combined use of AFP and several serological markers such as DCP, AFP-L3, and PIVKA-II (16) have been shown to improve HCC detection rate, the specificity and sensitivity of these markers are inadequate to provide early HCC diagnosis.